| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025754749 |
| P356 | DOI | 10.1016/S1071-3581(05)80003-0 |
| P698 | PubMed publication ID | 9420757 |
| P50 | author | Stanley Nattel | Q41778370 |
| P2093 | author name string | S Fraser | |
| D D Miller | |||
| H S Bom | |||
| D D Waters | |||
| G Heller | |||
| J Lette | |||
| J L Tatum | |||
| J Leppo | |||
| E B Stanton | |||
| P2860 | cites work | Vasodilator myocardial perfusion imaging: demonstration of local electrophysiological changes of ischaemia | Q28318600 |
| ST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates | Q28324551 | ||
| Effects of the dipyridamole test on left ventricular function in coronary artery disease | Q28324553 | ||
| The relationship between chest pain during thallium-201 scintigraphy with dipyridamole and myocardial ischemia | Q28328437 | ||
| The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group | Q28329296 | ||
| The incidence of serious hemodynamic changes in physically-limited patients following oral dipyridamole challenge before thallium-201 scintigraphy | Q28331739 | ||
| Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis | Q28332231 | ||
| Severe ischemic ventricular arrhythmia during dipyridamole scintigraphy | Q28333233 | ||
| Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 PET imaging | Q28334566 | ||
| Symptomatic bradycardia complicating the use of intravenous dipyridamole for thallium-201 myocardial perfusion imaging | Q28335555 | ||
| Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging | Q28335782 | ||
| Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers | Q34287858 | ||
| Exercise standards. A statement for health professionals from the American Heart Association | Q37994466 | ||
| Abnormal stress responses in patients with diseases affecting the sympathetic nervous system | Q40866864 | ||
| Role of adenosine in regulation of regional cerebral blood flow in sensory cortex | Q41215229 | ||
| Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography | Q41215342 | ||
| Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease | Q41675614 | ||
| Caffeine reduces dipyridamole-induced myocardial ischemia | Q42199494 | ||
| Myocardial infarction after dipyridamole-assisted thallium-201 imaging. | Q42199580 | ||
| Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly | Q42213287 | ||
| Cardiac Arrest during Dipyridamole Imaging | Q42213709 | ||
| Prolonged myocardial ischemia after intravenous dipyridamole thallium imaging | Q42220155 | ||
| Quantitative demonstration of dipyridamole-induced coronary steal and alteration by angioplasty in man: analysis by simultaneous, continuous dual Doppler spectral flow velocity | Q42286319 | ||
| Cerebrovascular accident associated with dipyridamole thallium-201 myocardial imaging: case report | Q42289215 | ||
| Dipyridamole testing in cerebrovascular patients. | Q42560124 | ||
| Death with dipyridamole-thallium imaging | Q42668193 | ||
| Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group | Q43495771 | ||
| False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion | Q43570458 | ||
| Dynamic cerebral and systemic circulatory effects of adenosine, theophylline and dipyridamole | Q44132525 | ||
| The clinical and pathophysiologic implications of pain, ST abnormalities, and scintigraphic changes induced during dipyridamole infusion: their relationships to the peripheral hemodynamic response | Q46043355 | ||
| The effect of intravenous dipyridamole on the cerebral and systemic circulations of the dog. | Q48876442 | ||
| Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. | Q53394079 | ||
| Cerebral and systemic circulatory effects of arterial hypotension induced by adenosine. | Q54503906 | ||
| Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry | Q60607132 | ||
| Regional and global biventricular function during dipyridamole stress testing | Q61046160 | ||
| Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial | Q67401523 | ||
| Adenosine's role in the genesis of bradyarrhythmias induced by acute myocardial hypoxia | Q67834994 | ||
| Arrhythmias during dipyridamole test. Report of 3 cases | Q67970095 | ||
| Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise | Q68001041 | ||
| Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase | Q68025221 | ||
| Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine | Q68034179 | ||
| Diagnostic value for coronary artery disease of chest pain during dipyridamole-thallium stress testing | Q68253205 | ||
| Caffeine and theophylline attenuate adenosine-induced vasodilation in humans | Q68580373 | ||
| [Systemic effects of intravenous dipyridamole in patients of various age groups] | Q68619601 | ||
| The role of dipyridamole in bronchospasm | Q68833288 | ||
| Ischemic ST-segment changes after dipyridamole infusion | Q68961153 | ||
| Systemic effects and safety of intravenous dipyridamole in elderly patients with suspected coronary artery disease | Q69461337 | ||
| Thallium-201 myocardial imaging during pharmacologic coronary vasodilation: comparison of oral and intravenous administration of dipyridamole | Q69518194 | ||
| Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging | Q69610448 | ||
| Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patients | Q69941884 | ||
| Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma | Q70728668 | ||
| Effect of adenosine and dipyridamole on cerebral blood flow | Q70782840 | ||
| A study on the noninvasive evaluation of coronary vasodilating drugs with thallium-201 myocardial imagings | Q71047460 | ||
| Evaluation of myocardial perfusion and left ventricular function by 201Tl scintigraphy after dipyridamole | Q71064617 | ||
| Ventricular dysrhythmias following intravenous dipyridamole during "stress" myocardial imaging | Q71820721 | ||
| Pulmonary uptake of PGE2 is inhibited by dipyridamole in rat isolated lungs | Q72039096 | ||
| Thallium myocardial perfusion tomography using intravenous dipyridamole combined with maximal dynamic exercise | Q72728658 | ||
| Dipyridamole and adenosine vasodilator stress for myocardial imaging: vive la différence! | Q72740819 | ||
| Arterial baroreflex regulation of blood pressure in patients with congestive heart failure | Q72740829 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3-17 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
| P1476 | title | Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study | |
| P478 | volume | 2 |
| Q36091069 | A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease |
| Q87366697 | ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers |
| Q46986484 | Acute myocardial infarction during regadenoson myocardial perfusion imaging |
| Q87224297 | Arrhythmias in vasodilator stress testing |
| Q45969460 | Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches. |
| Q40932491 | Bone regeneration in critical bone defects using three-dimensionally printed β-tricalcium phosphate/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP-2. |
| Q46535655 | Cardiogenic shock after dipyridamole administration for myocardial perfusion imaging |
| Q90378316 | Cerebrovascular steal phenomenon in a patient undergoing dipyridamole nuclear perfusion cardiac imaging |
| Q59802263 | Comparative Performances of Dipyridamole and Regadenoson to Detect Myocardial Ischemia using Cardiac Cadmium-Zinc-Telluride Single-Photon Emission Computerized Tomography |
| Q73420719 | Comparison of Tc-99m sestamibi perfusion imaging and echocardiography using an arbutamine infusion for the detection of coronary artery disease |
| Q46214418 | Comparison of diagnostic performances of three different software packages in detecting coronary artery disease |
| Q41301458 | Comparison of pharmacologic stress agents |
| Q33145183 | Complications of exercise and pharmacologic stress tests: differences in younger and elderly patients |
| Q41192665 | Complications of pharmacologic stress echocardiography in coronary artery disease |
| Q46894180 | Coronary steal and ST elevation during dipyridamole stress testing leading to coronary artery bypass grafting |
| Q53396311 | Design, rationale, and populations of an international outcomes and utilization study of pharmacologic stress SPECT myocardial perfusion imaging in contemporary practice. |
| Q43816417 | Dipyridamole administration at the end of an insufficient exercise Tc-99m MIBI SPECT improves detection of multivessel coronary artery disease in patients with previous myocardial infarction |
| Q33715248 | Dipyridamole stress echocardiography |
| Q77178283 | Dipyridamole-dobutamine stress with Tc-99m sestamibi tomographic myocardial perfusion imaging |
| Q33753542 | Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation. |
| Q35410561 | Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. |
| Q57623069 | EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology |
| Q43810301 | Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging |
| Q44416593 | Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging |
| Q89689452 | How Do PET Myocardial Blood Flow Reserve and FFR Differ? |
| Q46952901 | Induction of atrial depolarization abnormality during dipyridamole stress imaging: a cautionary note |
| Q44775900 | Influence of chronic renal failure on the heart rate response to dipyridamole in patients undergoing myocardial perfusion SPECT. |
| Q30310207 | Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation |
| Q52958006 | Left ventricular function in response to dipyridamole stress: head-to-head comparison between 82Rubidium PET and 99mTc-sestamibi SPECT ECG-gated myocardial perfusion imaging. |
| Q52911929 | Long-term prognostic significance of right bundle-branch morphology ventricular ectopy induced during stress test in patients with intermediate to high probability of coronary artery disease. |
| Q30371885 | Low Prevalance of Major Events Adverse to Exercise Stress Echocardiography. |
| Q35765832 | Myocardial perfusion scintigraphy: the evidence |
| Q34391783 | Nuclear cardiology update |
| Q83430233 | Patient-centered imaging |
| Q35031075 | Pharmacologic radionuclide myocardial perfusion imaging |
| Q30309283 | Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise |
| Q35097850 | Pharmacologic stress testing: new methods and new agents |
| Q73297016 | Pharmacologic stress testing: understanding the options |
| Q41301428 | Pharmacologic stress versus maximal-exercise stress for perfusion imaging: which, when, and why? |
| Q40800281 | Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry |
| Q33759396 | Pharmacological stress testing |
| Q53267694 | Predictors of abnormal heart rate response to dipyridamole in patients undergoing myocardial perfusion SPECT |
| Q48271472 | Regadenoson for myocardial perfusion imaging: Is it safe? |
| Q42539806 | Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipients |
| Q43787125 | SPECT dipyridamole scintigraphy for detecting coronary artery disease in patients with isolated severe aortic stenosis |
| Q44766516 | ST segment elevation during dipyridamole stress testing in a patient without coronary lesions |
| Q73614691 | Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS) |
| Q37735620 | Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease |
| Q87314084 | Safety of stress testing in patients with elevated cardiac biomarkers: Are all modalities created equal? |
| Q87342298 | Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers |
| Q32076658 | Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography |
| Q38480969 | Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies |
| Q42543041 | Severe transmural myocardial ischemia after dipyridamole administration implicating coronary steal |
| Q73132871 | Simultaneous dipyridamole/maximal subjective exercise with 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease |
| Q34600099 | Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). |
| Q37200102 | Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). |
| Q53507991 | Stress protocols and tracers. |
| Q36004976 | Stress testing and non-invasive coronary angiography in patients with suspected coronary artery disease: time for a new paradigm |
| Q73485733 | Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain |
| Q53053096 | The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging. |
| Q88108271 | The role of pharmacological stress testing in women |
| Q42552701 | Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging |
| Q33767682 | Unusual Dipyridamole-induced Aberrant Conduction in the Absence of Myocardial Ischemia |
| Q90674539 | Update of the Brazilian Guideline on Nuclear Cardiology - 2020 |
| Q84559814 | [Cardiac MRI: technical considerations] |
Search more.